SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    L. J. Peppone, S. Hebl, J. Q. Purnell, M. E. Reid, R. N. Rosier, K. M. Mustian, O. G. Palesh, A. J. Huston, M. N. Ling, G. R. Morrow, The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review, Osteoporosis International, 2010, 21, 7, 1133

    CrossRef

  2. 2
    Gary G. Schwartz, Vitamin D and Intervention Trials in Prostate Cancer: From Theory to Therapy, Annals of Epidemiology, 2009, 19, 2, 96

    CrossRef

  3. 3
    Deborah A. Bradley, Maha Hussain, Cora N. Sternberg, A new era in prostate cancer therapy: new targets and novel therapeutics, Targeted Oncology, 2008, 3, 1, 31

    CrossRef

  4. 4
    Joseph S. Chan, Tomasz M. Beer, David I. Quinn, Jacek K. Pinski, Mark Garzotto, Mitchell Sokoloff, Daniel R. Dehaze, Christopher W. Ryan, A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer, BJU International, 2008, 102, 11
  5. 5
    Robert Dreicer, Current status of cytotoxic chemotherapy in patients with metastatic prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2008, 26, 4, 426

    CrossRef

  6. 6
    Tomasz M. Beer, Christopher W. Ryan, Peter M. Venner, Daniel P. Petrylak, Gurkamal S. Chatta, J. Dean Ruether, Kim N. Chi, James Young, W. David Henner, Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer, Cancer, 2008, 112, 2
  7. 7
    Deborah A. Bradley, Maha Hussain, Promising Novel Cytotoxic Agents and Combinations in Metastatic Prostate Cancer, The Cancer Journal, 2008, 14, 1, 15

    CrossRef

  8. 8
    James Thorne, Moray J. Campbell, The vitamin D receptor in cancer, Proceedings of the Nutrition Society, 2008, 67, 02, 115

    CrossRef

  9. 9
    William M Brown, Vitamin D, vitamin D analogs (deltanoids) and prostate cancer, Expert Review of Clinical Pharmacology, 2008, 1, 6, 803

    CrossRef

  10. 10
    Gretchen A. Gignac, Michael J. Morris, Maha Hussain, Castration Resistant, Taxane Naïve Metastatic Prostate Cancer: Current Clinical Approaches and Future Directions, The Journal of Urology, 2007, 178, 3, S30

    CrossRef

  11. 11
    Zoya Lagunova, Alina Carmen Porojnicu, Arne Dahlback, Jens Petter Berg, Tomasz M. Beer, Johan Moan, Prostate cancer survival is dependent on season of diagnosis, The Prostate, 2007, 67, 12
  12. 12
    M.E. Leroux, E. Auzenne, R. Evans, N. Hail, W. Spohn, S.C. Ghosh, D. Farquhar, T. McDonnell, J. Klostergaard, Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells, The Prostate, 2007, 67, 15
  13. 13
    Richard D. Sowery, Alan I. So, Martin E. Gleave, Therapeutic options in advanced prostate cancer: Present and future, Current Urology Reports, 2007, 8, 1, 53

    CrossRef

  14. 14
    Roberto Petrioli, Alessandra Pascucci, Edoardo Francini, Stefania Marsili, Angela Sciandivasci, Giovanni De Rubertis, Gabriele Barbanti, Antonio Manganelli, Francesco Salvestrini, Guido Francini, Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel, BJU International, 2007, 100, 4
  15. 15
    Jillian L. Capodice, Aaron E. Katz, Anticancer Supplements and Botanicals to Prevent and Treat Cancer: Does Any Clinical Evidence Exist?, Seminars in Preventive and Alternative Medicine, 2006, 2, 1, 22

    CrossRef

  16. 16
    Earle F. Burgess, Bruce J. Roth, Changing Perspectives of the Role of Chemotherapy in Advanced Prostate Cancer, Urologic Clinics of North America, 2006, 33, 2, 227

    CrossRef

  17. 17
    Tomasz M. Beer, Peter M. Venner, Christopher W. Ryan, Daniel P. Petrylak, Gurkamal Chatta, J. Dean Ruether, Kim N. Chi, John G. Curd, Thomas G. DeLoughery, High dose calcitriol may reduce thrombosis in cancer patients, British Journal of Haematology, 2006, 135, 3
  18. 18
    Susan F. Slovin, Immunologic targeting: how to channel a minimal response for maximal outcome, Current Opinion in Urology, 2006, 16, 3, 179

    CrossRef

  19. 19
    Moray J Campbell, Luciano Adorini, The vitamin D receptor as a therapeutic target, Expert Opinion on Therapeutic Targets, 2006, 10, 5, 735

    CrossRef